Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
16,999,520
-
Share change
-
+16,672,631
-
Total reported value
-
$88,063,000
-
Put/Call ratio
-
4.9%
-
Price per share
-
$5.18
-
Number of holders
-
75
-
Value change
-
+$86,371,823
-
Number of buys
-
72
Institutional Holders of AEVI GENOMIC MEDICINE INC - COM (GNMX) as of Q4 2016
As of 31 Dec 2016,
AEVI GENOMIC MEDICINE INC - COM (GNMX) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,999,520 shares.
The largest 10 holders included
Broadfin Capital, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., JENNISON ASSOCIATES LLC, Opaleye Management Inc., VANGUARD GROUP INC, BlackRock Fund Advisors, BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Institutional Trust Company, N.A., and SPHERA FUNDS MANAGEMENT LTD..
This page lists
75
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.